Fungal infections in transplant recipients: pros and cons of immunosuppressive and antimicrobial treatment Comment

Nicolas Papon (1, 2) , Gilles Nevez (1, 3, 2) , Solene Le Gal (3, 1, 2) , Cecile Vigneau (4, 5) , Florence Robert-Gangneux (4, 5) , Jean-Philippe Bouchara (2, 6, 1) , Oliver A. Cornely (7, 8) , David W. Denning (9, 10) , Jean-Pierre Gangneux (4, 5)

1 ICAT - SFR UA 4208 Interactions Cellulaires et Applications Thérapeutiques
2 GEIHP - Groupe d'Étude des Interactions Hôte-Pathogène
3 CHRU Brest - Centre Hospitalier Régional Universitaire de Brest
4 Irset - Institut de recherche en santé, environnement et travail
5 Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Ponchaillou]
6 CHU Angers - Centre Hospitalier Universitaire d'Angers
7 DZIF - German Centre for Infection Research
8 University Hospital of Cologne [Cologne]
9 GAFFI - Global action fund for fungal infections [Geneva]
10 MAHSC - Manchester Academic Health Science Centre

Domaines: Sciences du Vivant [q-bio]

Nicolas Papon, Gilles Nevez, Solene Le Gal, Cecile Vigneau, Florence Robert-Gangneux, et al.. Fungal infections in transplant recipients: pros and cons of immunosuppressive and antimicrobial treatment Comment. The Lancet Microbe, 2021, 2 (1), pp.E6-E8. ⟨10.1016/S2666-5247(20)30199-3⟩. ⟨hal-03203135v2⟩